Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
BETIBEGLOGENE AUTOTEMCEL IV SUSP [190339] (NDC 7355431111) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 8, 2026 , from http://ppman.hank.ai/transparency/procedure/7355431111/by-state?code_type=NDC
“BETIBEGLOGENE AUTOTEMCEL IV SUSP [190339] (NDC 7355431111) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7355431111/by-state?code_type=NDC. Accessed
November 8, 2026 .
“BETIBEGLOGENE AUTOTEMCEL IV SUSP [190339] (NDC 7355431111) by State,” HANK Price Transparency ,
accessed November 8, 2026 ,
http://ppman.hank.ai/transparency/procedure/7355431111/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
7355431111 — Betibeglogene Autotemcel IV Susp [190339]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,284,080
National median
$57,174 – $2,100,000
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7355431111 (NDC), with interquartile range
State Median p25 p75
VA $1,284,080 $57,174 $2,100,000